Cargando…
Development of a Novel Highly Spontaneous Metastatic Model of Esophageal Squamous Cell Carcinoma Using Renal Capsule Technology
PURPOSE: Increasing evidence has demonstrated that animal models are imperative to investigate the potential molecular mechanism of metastasis and discover anti-metastasis drugs; however, efficient animal models to unveil the underlying mechanisms of metastasis in esophageal squamous cell carcinoma...
Autores principales: | Gao, Pan, Liu, Hongtao, Yang, Zhenzhen, Hui, Yiran, Shi, Zhuangzhuang, Yang, Zhen, Song, Min, Yao, Menghui, Fan, Wenfei, Yang, Jinhua, Hao, Yibin, Fan, Tianli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872218/ https://www.ncbi.nlm.nih.gov/pubmed/33574674 http://dx.doi.org/10.2147/OTT.S290564 |
Ejemplares similares
-
Copper transporter Ctr1 contributes to enhancement of the sensitivity of cisplatin in esophageal squamous cell carcinoma
por: Wang, Xin, et al.
Publicado: (2023) -
Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway
por: Fan, Tianli, et al.
Publicado: (2016) -
Constitutive activated STAT3 is an essential regulator and therapeutic target in esophageal squamous cell carcinoma
por: Tian, Fang, et al.
Publicado: (2017) -
Paclitaxel and cisplatin with or without cetuximab in metastatic esophageal squamous cell carcinoma: a randomized, multicenter phase II trial
por: Lu, Zhihao, et al.
Publicado: (2022) -
Cost-effectiveness analysis of camrelizumab in the second-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China
por: Yang, Fan, et al.
Publicado: (2021)